An audience with...Joseph Bolen. Interview by Bethan Hughes.
Nat Rev Drug Discov
; 8(8): 608, 2009 Aug.
Article
em En
| MEDLINE
| ID: mdl-19644470
Chief Scientific Officer, Millennium: The Takeda Oncology Company,Cambridge, Massachusetts, USA. Prior to joining Millennium, Joseph Bolen, Ph.d., held positions including Vice President and Global head of Oncologic diseases at hoechst Marion Roussel, and executive director of oncology drug discovery at the Bristol-Myers Squibb Pharmaceutical Research institute. in addition to other senior academic positions, he was Section Chief of the Biochemical Oncology Department at the National Cancer Institute in Maryland, USA, and a founding member of their laboratory of tumor virus biology.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Desenho de Fármacos
/
Indústria Farmacêutica
/
Antineoplásicos
Tipo de estudo:
Prognostic_studies
/
Qualitative_research
Limite:
Humans
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article